DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

休市中 05-03 16:00:00 EDT

0.6669

-0.0031

-0.46%

盘后0.6620

-0.0049-0.73%

16:00 EDT

最高0.6805	最低0.6500	成交量2.90万
今开0.6700	昨收0.6700	日振幅4.55%
总市值1.28亿	流通市值5,781万	总股本1.92亿
成交额1.92万	换手率0.03%	流通股本8,669万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":0.6669,"timestamp":1714766400000,"preClose":0.67,"halted":0,"volume":28964,"hourTrading":{"tag":"盘后","latestPrice":0.662,"preClose":0.6669,"latestTime":"16:00 EDT","volume":1,"amount":0.662,"timestamp":1714766401207},"delay":0,"floatShares":86688416,"shares":192422762,"eps":-0.382279,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0031,"latestTime":"05-03 16:00:00 EDT","open":0.67,"high":0.6805,"low":0.65,"amount":19191.654725,"amplitude":0.045522,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.382279,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":1,"listingDate":1413950400000,"adjPreClose":0.67,"adrRate":0.5,"postHourTrading":{"tag":"盘后","latestPrice":0.662,"preClose":0.6669,"latestTime":"16:00 EDT","volume":1,"amount":0.662,"timestamp":1714766401207},"volumeRatio":1.7238013586324548},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2429118016","title":"Dbv Technologies盘中异动 早盘股价大涨8.14%报0.715美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118016","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429118016?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:51","pubTimestamp":1713880292,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时51分，Dbv Technologies股票出现异动，股价大幅拉升8.14%。截至发稿，该股报0.715美元/股，成交量2367股，换手率0.00%，振幅0.02%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232151337a54ee7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232151337a54ee7e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428541246","title":"Dbv Technologies盘中异动 股价大涨6.26%报0.702美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428541246","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428541246?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:32","pubTimestamp":1713533575,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时32分，Dbv Technologies股票出现异动，股价急速上涨6.26%。截至发稿，该股报0.702美元/股，成交量1402股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.30%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192132557921e041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192132557921e041&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428659023","title":"Dbv Technologies盘中异动 股价大涨6.47%报0.724美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428659023","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428659023?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:04","pubTimestamp":1713449040,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时04分，Dbv Technologies股票出现异动，股价急速拉升6.47%。截至发稿，该股报0.724美元/股，成交量8268股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.47%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182204018b364fbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182204018b364fbf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426268930","title":"Dbv Technologies盘中异动 股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268930","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426268930?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:32","pubTimestamp":1712842346,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时32分，Dbv Technologies股票出现波动，股价快速上涨6.14%。截至发稿，该股报0.764美元/股，成交量155股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.23%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132268b109001&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132268b109001&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426319477","title":"Dbv Technologies盘中异动 早盘急速下跌9.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426319477","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426319477?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:33","pubTimestamp":1712669639,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时33分，Dbv Technologies股票出现异动，股价大幅下跌9.10%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.03%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040921340087e7edc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040921340087e7edc9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425919562","title":"Dbv Technologies股价飙升10.14% 市值涨396.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425919562","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425919562?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:59","pubTimestamp":1712329198,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时59分，Dbv Technologies股票出现异动，股价大幅拉升10.14%。截至发稿，该股报0.771美元/股，成交量4.653万股，换手率0.02%，振幅10.07%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.81%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522595887e7e2da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522595887e7e2da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424318046","title":"Dbv Technologies盘中异动 早盘快速拉升6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424318046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424318046?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:22","pubTimestamp":1712240522,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时22分，Dbv Technologies股票出现波动，股价急速上涨6.67%。截至发稿，该股报0.800美元/股，成交量1.4656万股，换手率0.01%，振幅6.67%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.05%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042222028af119e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042222028af119e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422091650","title":"Dbv Technologies盘中异动 快速上涨5.80%报0.821美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422091650","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422091650?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:27","pubTimestamp":1711549654,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时27分，Dbv Technologies股票出现波动，股价大幅拉升5.80%。截至发稿，该股报0.821美元/股，成交量4.8075万股，换手率0.02%，振幅1.88%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.53%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272227347a4f8a29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272227347a4f8a29&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422018546","title":"Dbv Technologies盘中异动 早盘股价大跌5.80%报0.750美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422018546","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422018546?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:27","pubTimestamp":1711376837,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时27分，Dbv Technologies股票出现异动，股价急速下挫5.80%。截至发稿，该股报0.750美元/股，成交量656股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.16%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325222718861e0e39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325222718861e0e39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417216606","title":"Dbv Technologies盘中异动 早盘大幅下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417216606","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417216606?lang=zh_cn&edition=full","pubTime":"2024-03-07 00:06","pubTimestamp":1709741179,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日00时06分，Dbv Technologies股票出现波动，股价大幅下挫5.31%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.27%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030700061987e768b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030700061987e768b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417449315","title":"Dbv Technologies盘中异动 早盘股价大跌6.10%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417449315","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417449315?lang=zh_cn&edition=full","pubTime":"2024-03-06 00:24","pubTimestamp":1709655850,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日00时24分，Dbv Technologies股票出现异动，股价大幅下挫6.10%。截至发稿，该股报0.800美元/股，成交量3.3883万股，换手率0.02%，振幅3.45%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.40%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，专注于通过开发一种名为 Viaskin 的新技术平台来改变免疫治疗领域。其主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060024107a49be82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060024107a49be82&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":-0.1108},{"period":"3month","weight":-0.259},{"period":"6month","weight":-0.3525},{"period":"1year","weight":-0.5725},{"period":"ytd","weight":-0.3001}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.是一家临床阶段专业生物制药公司，该公司专注于通过开发一个名为Viaskin的新的技术平台来改变免疫疗法领域。该公司的治疗方法是基于表皮免疫疗法（EPIT），该公司运用Viaskin新技术平台通过皮肤用专有的方法向免疫系统递送生物活性化合物。该公司是根据法兰西共和国法律注册成立于2002年3月29日。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.023953},{"month":2,"riseRate":0.5,"avgChangeRate":-0.00411},{"month":3,"riseRate":0.5,"avgChangeRate":0.002853},{"month":4,"riseRate":0.6,"avgChangeRate":0.072361},{"month":5,"riseRate":0.4,"avgChangeRate":-0.002082},{"month":6,"riseRate":0.333333,"avgChangeRate":0.064864},{"month":7,"riseRate":0.444444,"avgChangeRate":0.058444},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.044387},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.083505},{"month":10,"riseRate":0,"avgChangeRate":-0.203366},{"month":11,"riseRate":0.5,"avgChangeRate":0.029107},{"month":12,"riseRate":0.7,"avgChangeRate":-0.003851}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}